CLIA Final Rules for Quality Systems: Quality Assesment Issues and Answers
Description:
Together with Dr. Sharon S. Ehrmeyer, PhD, MT(ASCP), Dr. Teresa Darcy, MD, FACP, and with an introduction by Dr. Ronald R. Laessig, PhD, Dr. Westgard has written a new book that explains the practical impact of the new regulations and interpretive guidelines: This new manual provides thorough coverage of the key changes in the CLIA Final Rule, as well as in-depth analysis of the new laboratory responsibilities that the regulations have created. But this manual is more than a compliance guide: * It explains the method validation requirements and details how to organize the statistical studies now required for all new non-waived methods. * It dispels the confusion about waived, non-waived, moderate, and high complexity methods * It defines the new calibration and calibration verification requirements. * It describes the final QC requirements, as well as an overview of a QC Planning and Design process to "Do the Right QC Right" * It provides an authoritative judgment on the new "equivalent QC procedures" * and more...
Best prices to buy, sell, or rent ISBN 9781886958203
Frequently Asked Questions about CLIA Final Rules for Quality Systems: Quality Assesment Issues and Answers
The price for the book starts from $79.99 on Amazon and is available from 4 sellers at the moment.
If you’re interested in selling back the CLIA Final Rules for Quality Systems: Quality Assesment Issues and Answers book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the CLIA Final Rules for Quality Systems: Quality Assesment Issues and Answers book, the best buyback offer comes from and is $ for the book in good condition.
The CLIA Final Rules for Quality Systems: Quality Assesment Issues and Answers book is in very low demand now as the rank for the book is 8,229,943 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.